Polymorphs of ethyl 3-[(2-{(4-(hexyloxycarbonylamino-imino methyl)phenylamino]methyl}-1-methyl-1 H-benzimidazole5-carbonyl)pyridin-2-ylamino)propionate
Details for Australian Patent Application No. 2006256778 (hide)
International Classifications
Event Publications
10 January 2008 PCT application entered the National Phase
PCT publication WO2006/131491 Priority application(s): WO2006/131491
13 March 2008 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Boehringer Ingelheim International GmbH, Application No. 2006256778, Under INID (54), correct the title to Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenylamino]methyl}-1methyl-1H-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006256783-HDAC regulation assays, compounds and therapeutic compositions
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser